Approaches to Deprescribing Proton Pump Inhibitors in Clinical Practice: A Systematic Review

被引:0
|
作者
Rossi, Andrea [1 ,2 ]
Perrella, Lara [3 ]
Scotti, Stefano [2 ]
Olmastroni, Elena [1 ,2 ]
Galimberti, Federica [2 ]
Ardoino, Ilaria [4 ]
Orlando, Valentina [3 ]
Menditto, Enrica [3 ]
Franchi, Carlotta [4 ]
Casula, Manuela [1 ,2 ]
机构
[1] Univ Milan, Dept Pharmacol & Biomol Sci DiSFeB, Epidemiol & Prevent Pharmacol Serv SEFAP, I-20133 Milan, Italy
[2] IRCCS Multimed, I-20099 Sesto San Giovanni, Italy
[3] Univ Naples Federico II, Ctr Pharmacoecon & Drug Utilizat Res CIRFF, Dept Pharm, I-80138 Naples, Italy
[4] Ist Ric Farmacolog Mario Negri IRCCS, Dept Hlth Policy, Lab Pharmacoepidemiol & Human Nutr, I-20156 Milan, Italy
关键词
proton pump inhibitors (PPIs); deprescribing; intervention; symptoms; GASTROESOPHAGEAL-REFLUX DISEASE; ON-DEMAND-THERAPY; LONG-TERM TREATMENT; PANTOPRAZOLE; 20; MG; STEP-DOWN; QUALITY-IMPROVEMENT; PRIMARY-CARE; MAINTENANCE THERAPY; CONTROLLED-TRIAL; OLDER PATIENTS;
D O I
10.3390/jcm13206283
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Proton pump inhibitors (PPIs) are some of the most frequently prescribed medications, but they are often used inappropriately, either being prescribed without a clear indication or continued for longer than necessary. In such cases, deprescribing is recommended. However, despite its proven effectiveness, the implementation of deprescribing in clinical practice remains inconsistent and varied, making it challenging to identify the most effective strategies. The goal is to provide a comprehensive outline of deprescribing interventions for PPI therapy implemented across various settings and by different healthcare professionals. Methods: The study is designed to be a systematic review of the published literature. PubMed, Embase, and Web of Science databases were searched from 1 January 1989 (the first PPI on the market) to 30 September 2024 for articles assessing PPI deprescribing in adult patients, focusing on the implementation rate (primary outcome) or effects on symptoms (secondary outcome). Results: After screening, 66 studies were included, predominantly pragmatic trials (N = 32) or randomized controlled trials (N = 25). We found a variety of interventions promoting PPI deprescription. Collaborative efforts involving multiple healthcare professionals, the use of algorithms for clinical decision-making, and patient involvement have proven to be key elements in the most effective strategies. Discontinuing therapy may not be advisable in cases of recurrent symptoms, suggesting that on-demand therapy could be a recommended approach. Deprescribing is particularly relevant for individuals with mild illnesses and symptoms, where tapering can effectively mitigate the rebound symptoms often associated with abrupt discontinuation. Conclusions: Given the current prevalence of inappropriate PPI prescribing, it is imperative to raise awareness among both physicians and patients about the importance of the deprescribing process, which should be tailored to the specific needs of each patient, considering his/her medical history, current health status, and personal preferences.
引用
收藏
页数:20
相关论文
共 50 条
  • [1] Deprescribing proton pump inhibitors Evidence-based clinical practice guideline
    Farrell, Barbara
    Pottie, Kevin
    Thompson, Wade
    Boghossian, Taline
    Pizzola, Lisa
    Rashid, Farah Joy
    Rojas-Fernandez, Carlos
    Walsh, Kate
    Welch, Vivian
    Moayyedi, Paul
    CANADIAN FAMILY PHYSICIAN, 2017, 63 (05) : 354 - 364
  • [2] Deprescribing proton pump inhibitors
    Turner, Justin P.
    Thompson, Wade
    Reeve, Emily
    Bell, J. Simon
    AUSTRALIAN JOURNAL OF GENERAL PRACTICE, 2022, 51 (11) : 845 - 848
  • [3] Deprescribing Proton Pump Inhibitors
    Zed, Peter J.
    CANADIAN JOURNAL OF HOSPITAL PHARMACY, 2018, 71 (05): : 291 - 292
  • [4] Deprescribing Proton Pump Inhibitors: Updated Clinical Guidelines
    Gaulke, Carolyn
    JNP- THE JOURNAL FOR NURSE PRACTITIONERS, 2024, 20 (09):
  • [5] Deprescribing proton pump inhibitors
    Teh, Kim Jun Kevin
    Puar, Hai Kiat Troy
    How, Choon How
    Tan, Teck Kiang Malcolm
    SINGAPORE MEDICAL JOURNAL, 2023, 64 (08) : 503 - 507
  • [6] Deprescribing Proton Pump Inhibitors
    Kurlander, Jacob E.
    Gonzalez, Juan J.
    Saini, Sameer D.
    JAMA INTERNAL MEDICINE, 2020, 180 (12) : 1711 - 1712
  • [7] Deprescribing strategies for proton pump inhibitors
    Young, Julia
    Fuller, Jordan A.
    Guidry, Corey M.
    JAAPA-JOURNAL OF THE AMERICAN ACADEMY OF PHYSICIAN ASSISTANTS, 2024, 37 (11): : 51 - 51
  • [8] Deprescribing Proton Pump Inhibitors Reply
    McDonald, Emily G.
    Lee, Todd C.
    JAMA INTERNAL MEDICINE, 2020, 180 (12) : 1712 - 1712
  • [9] An Emulated Clinical Trial of Deprescribing Proton Pump Inhibitors in Patients With Cirrhosis
    Tapper, Elliot
    Zhao, Zhe
    Parikh, Neehar
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (01): : 203 - 205
  • [10] Problems Associated with Deprescribing of Proton Pump Inhibitors
    Helgadottir, Holmfridur
    Bjornsson, Einar S.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (21)